ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 100 filers reported holding ANTARES PHARMA INC in Q2 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $99,000 | -59.1% | 30,000 | -62.5% | 0.00% | 0.0% |
| Q1 2019 | $242,000 | -31.6% | 80,000 | -38.5% | 0.00% | -50.0% |
| Q4 2018 | $354,000 | +31.6% | 130,000 | +62.5% | 0.00% | +100.0% |
| Q3 2018 | $269,000 | -19.7% | 80,000 | -38.5% | 0.00% | -50.0% |
| Q2 2018 | $335,000 | +17.1% | 130,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $286,000 | +10.4% | 130,000 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $259,000 | -38.5% | 130,000 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $421,000 | +0.5% | 130,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $419,000 | +84.6% | 130,000 | +62.5% | 0.00% | +100.0% |
| Q1 2017 | $227,000 | +845.8% | 80,000 | +607.3% | 0.00% | – |
| Q2 2015 | $24,000 | – | 11,310 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
| JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
| Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
| Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
| PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
| MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
| FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |